Reviva Pharmaceuticals Holdings (RVPH) Assets (2018 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) posted Assets of $23.6 million for Q1 2026, up 47.96% sequentially from $15.9 million in Q4 2025, and up 232.9% YoY from $7.1 million in Q1 2025.
Reviva Pharmaceuticals Holdings (RVPH) Assets (2018 - 2026) Analysis & Trends
Reviva Pharmaceuticals Holdings has reported Assets for 9 years, with the latest figure at $23.6 million in Q1 2026.
- Quarterly Assets rose 232.9% year-over-year to $23.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.6 million (up 232.9% YoY) and the FY2025 annual result came in at $15.9 million, up 2.71% from the prior year.
- Assets climbed to $23.6 million in Q1 2026 per RVPH's latest filing, from $15.9 million in the prior quarter.
- Over five years, Assets peaked at $25.3 million in Q1 2022 and troughed at $5.4 million in Q3 2023.
- A 5-year average of $15.3 million and a median of $14.3 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2023: Assets soared 279.51% in 2022, then tumbled 77.59% in 2023.
- Over 5 years, Assets stood at $18.9 million in 2022, then rose by 25.24% to $23.7 million in 2023, then plunged by 34.59% to $15.5 million in 2024, then rose by 2.71% to $15.9 million in 2025, then soared by 47.96% to $23.6 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $23.6 million, $15.9 million, and $14.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | 19.82 Bn |
| 10 | Reviva Pharmaceuticals Holdings | 6.40 Mn | 6.40 Mn | - | 21.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.14 Mn |
| Mar 31, 2026 | 23.56 Mn |
| Dec 31, 2025 | 15.92 Mn |
| Sep 30, 2025 | 14.33 Mn |
| Jun 30, 2025 | 11.63 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Dec 31, 2024 | 15.50 Mn |
| Sep 30, 2024 | 7.63 Mn |
| Jun 30, 2024 | 8.05 Mn |
| Mar 31, 2024 | 13.50 Mn |
| Dec 31, 2023 | 23.70 Mn |
| Sep 30, 2023 | 5.39 Mn |
| Jun 30, 2023 | 11.84 Mn |
| Mar 31, 2023 | 12.90 Mn |
| Dec 31, 2022 | 18.92 Mn |
| Sep 30, 2022 | 24.04 Mn |
| Jun 30, 2022 | 20.64 Mn |
| Mar 31, 2022 | 25.27 Mn |
| Sep 30, 2021 | 33.89 Mn |
| Jun 30, 2021 | 36.53 Mn |